FDA inspection
Celltex Therapeutics Corporation: FDA inspection ending Apr 27, 2012
FDA inspection 781924 · Official Action Indicated (OAI) · Houston, TX
Key facts
| Inspection ID | 781924 |
|---|---|
| Firm | Celltex Therapeutics Corporation |
| FEI number | 3009499974 |
| Address | 2401 Fountain View Dr, Suite 1020 |
| City | Houston |
| State | TX |
| ZIP | 77057 |
| Country | United States |
| Fiscal year | 2012 |
| Inspection end date | Apr 27, 2012 |
| Classification | Official Action Indicated (OAI) |
| Project area | Human Cellular, Tissue, and Gene Therapies |
| Product type | Biologics |
At a glance
- 10–99 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data